The Promise(s) of Mesenchymal Stem Cell Therapy in Averting Preclinical Diabetes: Lessons from In Vivo and In Vitro Model Systems

Investigators showed that intramuscular injection of placental (P)-MSCs homed more towards the visceral site, restored HOMA-IR and glucose homeostasis in the WNIN/GR-Ob rats. P-MSC therapy was effective in re-establishing the dysregulated cytokines.